Trichoderma spp. By Tricia Lobo. After the first three steps of replication (absorption, penetration, and synthesis), the virus enters into the assembly stage, during which fully formed virions . U.S.A. 74, 50885090. New microorganisms still need to be evaluated for efficiency, more precise methods for immobilizing microbial cells still need to be developed, and the induction techniques need to be continuously evaluated because they may vary in terms of their efficiency depending on the analyte. Selection of -lyase-producing yeasts improves aromatic thiol release and, consequently, the sensory properties of wines (Belda et al., 2016), whereas the selection of yeasts specializing in certain processes such as flocculation may improve the fermentation of special wines such as sparkling wines (Tofalo et al., 2016). Microbial techniques (selection, isolation ofpureculture,muta-tion,protoplast fusion, etc. Food. Bioresour. 363:fnw134. (2001). Microb. (2016). doi: 10.1094/PDIS.2003.87.1.4, Huang, C., Guo, H.-J., Xiong, L., Wang, B., Shi, S.-L., Chen, X.-F., et al. 349, 12891307. doi: 10.1017/S0003598X00094837, Valli, M., Sauer, M., Branduardi, P., Borth, N., Porro, D., and Mattanovich, D. (2006). doi: 10.1016/j.chom.2017.02.016, Boyer, L. R., Feng, W., Gulbis, N., Hadju, K., Harrison, R. J., Jeffries, P., et al. Microorganisms are majorly used for the production of industrial enzymes through the safe gene transfer methods. doi: 10.1016/j.carbpol.2016.06.017, Liao, J. C., Mi, L., Pontrelli, S., and Luo, S. (2016). The integrated processes for wastewater treatment based on the principle of microbial fuel cells: a review. The most prominent disease being studied with proteomic approaches is cancer, but this area of study is also being applied to infectious diseases. (2013). Implantable applications of chitin and chitosan. doi: 10.1080/09583157.2015.1089216, Xu, L., Zhao, Y., Doherty, L., Hu, Y., and Hao, X. 12: Modern Applications of Microbial Genetics, { "12.01:_Microbes_and_the_Tools_of_Genetic_Engineering" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "12.02:_Visualizing_and_Characterizing_DNA" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "12.03:_Whole_Genome_Methods_and_Industrial_Applications" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "12.04:_Genetic_Engineering_-_Risks_Benefits_and_Perceptions" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "12.E:_Modern_Applications_of_Microbial_Genetics_(Exercises)" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()" }, { "00:_Front_Matter" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "01:_An_Invisible_World" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "02:_How_We_See_the_Invisible_World" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "03:_The_Cell" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "04:_Prokaryotic_Diversity" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "05:_The_Eukaryotes_of_Microbiology" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "06:_Acellular_Pathogens" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "07:_Microbial_Biochemistry" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "08:_Microbial_Metabolism" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "09:_Microbial_Growth" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "10:_Biochemistry_of_the_Genome" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "11:_Mechanisms_of_Microbial_Genetics" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "12:_Modern_Applications_of_Microbial_Genetics" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "13:_Control_of_Microbial_Growth" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "14:_Antimicrobial_Drugs" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "15:_Microbial_Mechanisms_of_Pathogenicity" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "16:_Disease_and_Epidemiology" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "17:_Innate_Nonspecific_Host_Defenses" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "18:_Specific_Adaptive_Host_Defenses" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "19:_Diseases_of_the_Immune_System" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "20:_Laboratory_Analysis_of_the_Immune_Response" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "21:_Skin_and_Eye_Infections" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "22:_Respiratory_System_Infections" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "23:_Urogenital_System_Infections" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "24:_Digestive_System_Infections" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "25:_Circulatory_and_Lymphatic_System_Infections" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "26:_Nervous_System_Infections" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()", "zz:_Back_Matter" : "property get [Map MindTouch.Deki.Logic.ExtensionProcessorQueryProvider+<>c__DisplayClass228_0.b__1]()" }, 12.3: Whole Genome Methods and Industrial Applications, [ "article:topic", "authorname:openstax", "genomics", "Transcriptomics", "proteomics", "Metagenomics", "bioinformatics", "Reporter genes", "recombinant DNA pharmaceuticals", "RNA interference", "showtoc:no", "license:ccby", "licenseversion:40", "source@https://openstax.org/details/books/microbiology" ], https://bio.libretexts.org/@app/auth/3/login?returnto=https%3A%2F%2Fbio.libretexts.org%2FBookshelves%2FMicrobiology%2FMicrobiology_(OpenStax)%2F12%253A_Modern_Applications_of_Microbial_Genetics%2F12.03%253A_Whole_Genome_Methods_and_Industrial_Applications, \( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}}}\) \( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash{#1}}} \)\(\newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\) \( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\) \( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\) \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\) \( \newcommand{\Span}{\mathrm{span}}\) \(\newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\) \( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\) \( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\) \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\) \( \newcommand{\Span}{\mathrm{span}}\)\(\newcommand{\AA}{\unicode[.8,0]{x212B}}\), 12.4: Genetic Engineering - Risks, Benefits, and Perceptions, Genomics, Transcriptomics, and Proteomics, Recombinant DNA Technology and Pharmaceutical Production, http://www.rxlist.com/recombivax-drug.htm, source@https://openstax.org/details/books/microbiology, status page at https://status.libretexts.org, Treatment of heart disease (e.g., congestive heart failure), kidney disease, high blood pressure, Treatment of viscous lung secretions in cystic fibrosis, Treatment of severe anemia with kidney damage, Treatment of growth hormone deficiency, Turners syndrome, burns, Treatment of multiple sclerosis, various cancers (e.g., melanoma), viral infections (e.g., Hepatitis B and C), Treatment of pulmonary embolism in ischemic stroke, myocardial infarction, Explain the uses of genome-wide comparative analyses, Summarize the advantages of genetically engineered pharmaceutical products. Attenuated vaccines have been efficiently developed for a range of diseases: mumps, polio (Sabin), rubella, measles, smallpox, chickenpox, tuberculosis, yellow fever, and dengue. How is genomics different from traditional genetics? Alginate biosynthesis factories in Pseudomonas fluorescens: localization and correlation with alginate production level. 2, 854858. The prospection of lactic acid bacteria present in products fermented with various cultures (e.g., Satish et al., 2013; Mokoena et al., 2016) has created new sources of probiotics and the discovery of strains that can improve the quality of fermented products. Sci. J. Ind. Quart. Biotechnol. f. sp. Legal. 26, 503508. The production of second-generation ethanol, for example, obtained from lignocellulosic biomass, already occurs in some countries, although improvements are still needed to make the technology economically competitive. Brown, J., and Lauderdale, C. (2006). J. Genet. Nutr. B. burgdorferi is not easily cultured in the laboratory, and the initial symptoms can be very mild and resemble those of many other diseases. Int. 9, 749759. 1. Appl. Environ. Acta 568, 200210. (2002). Sci. FEMS Microbiol. A large number of substances with nanomedical application have emerged, including polymers, metallic nanoparticles, magnetic nanoparticles, VLPs, virions or virion components, and a growing diversity of self-organized protein materials, some with adjustable biomechanical properties such as stiffness, elasticity, adhesion or controllable disintegration or release of incorporated functional blocks or conventional chemical drugs (Rodriguez-Carmona and Villaverde, 2010).